Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Mary L. Smith > Profile

Mary L. Smith

Affiliations

Chief Development Officer at Springworks Therapeutics Inc. (SWTX), 2024-01-09

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
SWTX	$55.97	10,000	$559,675.00	167,511	2021-10-13	Filing
SWTX	$68.07	10,000	$680,723.00	167,511	2021-04-13	Filing
SWTX	$78.70	10,000	$787,016.00	167,511	2021-01-20	Filing